Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinosarcomas Uterine”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)WithdrawnNCT04149275
What this trial is testing

Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma

Who this might be right for
Carcinosarcoma of OvaryCarcinosarcoma of UterusCarcinosarcoma of Vagina
University of Alabama at Birmingham
Not applicableStudy completedNCT04458597
What this trial is testing

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

Who this might be right for
Endometrioid AdenocarcinomaSerous CarcinomaClear Cell Carcinoma+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03367741
What this trial is testing

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
National Cancer Institute (NCI) 82
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Testing effectiveness (Phase 2)Looking for participantsNCT04065269
What this trial is testing

ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

Who this might be right for
Gynaecological Cancers
Institute of Cancer Research, United Kingdom 174
Early research (Phase 1)Active Not RecruitingNCT03120624
What this trial is testing

VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer

Who this might be right for
Metastatic Endometrial CarcinomaRecurrent Endometrial AdenocarcinomaRecurrent Endometrial Carcinoma+7 more
Mayo Clinic 34
Testing effectiveness (Phase 2)UnknownNCT03570437
What this trial is testing

Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?

Who this might be right for
CarcinosarcomaEndometrial Neoplasms
University of Manchester 124
Large-scale testing (Phase 3)Study completedNCT00002546
What this trial is testing

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group 216
Testing effectiveness (Phase 2)Study completedNCT00238121
What this trial is testing

Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer

Who this might be right for
Recurrent Uterine SarcomaStage III Uterine SarcomaStage IV Uterine Sarcoma+1 more
National Cancer Institute (NCI) 56
Not applicableEnded earlyNCT01367301
What this trial is testing

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

Who this might be right for
Stage IA Uterine SarcomaStage IB Uterine SarcomaStage IC Uterine Sarcoma+8 more
Albert Einstein College of Medicine 14
Testing effectiveness (Phase 2)Study completedNCT00032162
What this trial is testing

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+2 more
AGO Study Group 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT02203760
What this trial is testing

Pazopanib Vs. Pazopanib Plus Gemcitabine

Who this might be right for
Leiomyosarcoma or Carcinosarcoma
North Eastern German Society of Gynaecological Oncology 58
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT03668340
What this trial is testing

AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma

Who this might be right for
Uterine Cancer
Dana-Farber Cancer Institute 49
Early research (Phase 1)Looking for participantsNCT04704661
What this trial is testing

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Who this might be right for
Advanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Ended earlyNCT00003156
What this trial is testing

Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group
Large-scale testing (Phase 3)Looking for participantsNCT03422198
What this trial is testing

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Serous Adenocarcinoma+6 more
University of Utah 188
Load More Results